oligog cf-5/20
Small moleculeexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2009 (NCT00970346)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- oligog cf-5/20
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03822455 | Phase 2/Phase 3 (Phase 3) | Apr 3, 2019 | AlgiPharma AS |
| NCT01991028 | Phase 2 | Apr 1, 2014 | AlgiPharma AS, Bio-Images Research Ltd |
| NCT01465529 | Phase 1/Phase 2 (Phase 2) | May 1, 2011 | AlgiPharma AS, University of Liverpool |
| NCT00970346 | Phase 1 | Sep 1, 2009 | AlgiPharma AS, Simbec-Orion, Smerud Medical Research Denmark |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AlgiPharma AS | For profit | 4 | 3 | 3 | 2009 |
| Bio-Images Research Ltd | For profit | 1 | 1 | 1 | 2014 |
| Simbec-Orion | For profit | 1 | 0 | 1 | 2009 |
| Smerud Medical Research Denmark | For profit | 1 | 0 | 1 | 2009 |
| University of Liverpool | Academic/Hospital | 1 | 0 | 1 | 2011 |
5 organizations
Page 1 / 1